NextCure (NXTC) Net earnings per share growth forecast for next year

Symbol and logo of brand NextCure Corp (NXTC)

NextCure, Inc. (NXTC) is minimizing risks by exploring new methods to combat tumor resistance through innovative antibodies. The consensus forward-looking EPS growth forecast visualizes these expectations, where the 78.30 level captures the current state. Successes in clinical trials and partnerships with pharma behemoths are driving growth. Stable demand for healthcare makes the company resilient to macro cycles, tying its development to product commercialization.

NXTC - NextCure Corp Earnings growth forecast for next year over the range 07/04/2022 - 11/12/2026

Metric breakdowns and analytics for nextcure.com (NXTC)

- price and consensus price forecast:
Price Chart NextCure Corp|NXTC - Consensus Target
- market capitalization details:
Market Value NextCure|NXTC - Real Price to Acquire Entire Company
- company book value details:
Accounting Value per Share NextCure|NXTC - Book Capitalization|Market Value to Book Value Ratio nextcure.com|NXTC - Total Business Assets
- company liabilities and liquidity data:
Debt to Equity NextCure, Inc.|NXTC - Long-Term Liabilities to Capital|Short-Term Debt to Equity Ratio NextCure|NXTC - Company Total Indebtedness|Debt to Book Value NextCure|NXTC - Amount of Long-Term Liabilities|Company Short-Term Debts NextCure|Quick Ratio nextcure.com
- earnings and market ratios statistics:
NXTC - Company Net Income|Expected Profit NextCure, Inc.|NXTC - Company Value to Net Income|Forward P/E Multiple NextCure, Inc.|NXTC - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization NextCure|NXTC - Profit before deduction of interest, taxes, depreciation and amortization|Net earnings per share for the last 12 months NextCure|NXTC - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months nextcure.com|NXTC - Earnings per share growth this year|Earnings growth forecast for next year NextCure, Inc.
Analysis of all company metrics:NextCure Corp
Core merchandise of NextCure Inc

NextCure, Inc. (NXTC) is investing its accumulated reserves into costly immuno-oncology drug development, which temporarily precludes operating profit. Analyzing this earnings per share forecast chart reveals analysts' calculated expectations for next year's EPS dynamics, recorded at 78.30. This metric measures the pace of profitability recovery, allowing investors to assess the timeline for the biotech's transition from a cash-burn stage to profitability.

Direct competitors

Net earnings per share growth forecast for next year ImmunityBio Corp|Expected earnings per share growth for next year Immunocore Corp (IMCR)|Net earnings per share growth forecast for next year Janux Therapeutics (JANX)|Expected earnings per share growth for next year arcusbio.com RCUS|Zymeworks - Expected earnings per share growth for next year|Earnings growth forecast for next year Tango Therapeutics Inc TNGX|IOVA - Net earnings per share growth forecast for next year|IMTX (Immatics Biotechnologies) - Projected earnings per share growth rate for next year|Xencor, Inc. (XNCR) - Net earnings per share growth forecast for next year|Expected net earnings per share growth next year compasstherapeutics.com (CMPX)|Expected earnings per share growth for next year REPL|LYEL - Net earnings per one share growth forecast for next year|Expected earnings per share growth for next year IPHA (Innate Pharma, S.A.)|Projected earnings per share increase next year PYXS|Earnings growth forecast for next year CGEN (Compugen)|Expected earnings per share trend next year IOBT|Sutro Biopharma - Earnings growth forecast for next year|Expected net earnings per share growth next year MiNK Therapeutics Inc.|werewolftx.com (HOWL) - Net earnings per share growth forecast for next year|Immix Biopharma - Expected earnings per share trend next year|ALXO (ALX Oncology Holdings) - Earnings growth forecast for next year|Earnings growth forecast for next year cuebiopharma.com|Net earnings per share growth forecast for next year PDS Biotechnology (PDSB)|SONN: Net earnings per share change forecast for next year|MAIA Biotechnology Inc - Expected earnings per share growth for next year|Liminatus (LIMN) - Expected net earnings per share growth next year|LVTX - Net earnings per share growth forecast for next year|LPTX (Leap Therapeutics, Inc.) - Projected earnings per share growth rate for next year|INTS: Earnings growth forecast for next year|Expected net earnings per share growth next year Sensei Biotherapeutics, Inc. (SNSE)|Expected earnings per share growth for next year TOVX|Projected earnings per share growth rate for next year GRTS (Gritstone Bio)|Expected earnings per share growth for next year KA (Kineta, Inc.)|Projected earnings per share increase next year NEXI|Earnings growth forecast for next year TSBX (Turnstone Biologics Corp.)|VCNX - Expected earnings per share growth for next year|HARP: Expected earnings per share growth for next year